Loading...
Market
What will be the level of Absci's adoption of AMD tech in AI pipeline by mid-2026?
2
Resolution / Starting Odds
Fully adopted across all pipelines • 25%
Partially adopted in some pipelines • 25%
Minimal adoption • 25%
Not adopted • 25%
Absci Corporation's technology adoption reports or official announcements
Story
AMD Invests $20M in AI-Driven Absci Structured as PIPE to Boost Drug Discovery Efforts
Jan 8, 2025, 11:50 AM
Advanced Micro Devices (AMD) has made a $20 million investment in Absci Corporation (ABSI), a company focused on AI-driven drug discovery. This strategic investment, reported by the Wall Street Journal, is part of AMD's initiative to market its AI semiconductors to the healthcare sector. The investment is structured as a private investment in public equity (PIPE) and aims to assist Absci in reducing its hardware costs by migrating some of its workloads to AMD's technology. This move underscores AMD's commitment to expanding its presence in the healthcare industry through innovative AI applications.
View original story
Similar markets
20% to 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
More than 30% • 25%
AMD GPUs outperform Nvidia GPUs • 25%
Nvidia GPUs outperform AMD GPUs • 25%
Performance is similar • 25%
No clear comparison available • 25%
More than 3 new partnerships • 25%
No new partnerships • 25%
1 new partnership • 25%
2 to 3 new partnerships • 25%
Yes • 50%
No • 50%
More than 1,000,000 • 25%
750,001 to 1,000,000 • 25%
500,000 to 750,000 • 25%
Less than 500,000 • 25%
Oracle • 25%
Microsoft • 25%
Meta • 25%
TensorWave • 25%
Meta • 25%
Microsoft • 25%
Amazon • 25%
Google • 25%
Nvidia loses significant market share • 25%
Nvidia faces strong competition but stays competitive • 25%
Nvidia remains the leader • 25%
Nvidia partners or merges with another major tech company • 25%